Low Dose Naltrexone Designated Orphan Drug for Complex Regional Pain Syndrome
Soin Therapeutics has been granted the Food and Drug Administration (FDA)’s Orphan Drug designation for the use of low dose naltrexone in the treatment of complex regional pain syndrome (CRPS). According to the Company, anecdotal…